Profiel
Omid Karkouti is the founder of two companies.
He founded Reformer Therapeutics, Inc. and Rarebase, PBC.
At Reformer Therapeutics, Inc., he holds no specific title.
At Rarebase, PBC, he held the title of Chief Operating Officer, but was no longer active in that role.
Actieve functies van Omid Karkouti
| Bedrijven | Functie | Begin |
|---|---|---|
Rarebase, PBC
 Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation. | Oprichter | - |
Eerdere bekende functies van Omid Karkouti
| Bedrijven | Functie | Einde |
|---|---|---|
Reformer Therapeutics, Inc.
 Reformer Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Reformer Therapeutics, Inc. develops therapy for cancer treatment. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Reformer Therapeutics, Inc.
Reformer Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Reformer Therapeutics, Inc. develops therapy for cancer treatment. | Health Services |
Rarebase, PBC
Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation. | Technology Services |
